International Vaccine Institute
61
6
6
34
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
6.6%
4 terminated/withdrawn out of 61 trials
89.5%
+3.0% vs industry average
31%
19 trials in Phase 3/4
6%
2 of 34 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (61)
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of the rSm-p80 + GLA-SE (SchistoShield®) Candidate Vaccine in Healthy Adults in Burkina Faso and Madagascar
Role: lead
Safety and Immunogenicity Study of the DuoChol Oral Cholera Vaccine in Healthy Participants
Role: lead
Effectiveness of Malaria Vaccines in Reducing the Risk of Invasive Non-typhoidal Salmonella Disease
Role: lead
Strengthening HPV Immunization Through EPI Leveraged Delivery
Role: lead
Trial to Evaluate Immunogenicity Non-Inferiority, Safety and Lot-to-Lot Consistency of Biovac OCV-S to Euvichol®-Plus
Role: lead
Evaluation of Effectiveness and Safety of LC16m8 Mpox Vaccine in the Democratic Republic of Congo (DRC)
Role: lead
Global Burden Estimation of Human Papillomavirus (GLOBE-HPV)
Role: lead
Seamless Controlled Trial To Evaluate Safety And Immunogenicity of Chikungunya Vaccine in LatinAmerica and Asia
Role: lead
Immunogenicity and Safety of Hecolin® in HIV Positive/Negative Adults and in Children
Role: lead
Dose Escalation Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Healthy Adults
Role: lead
Hepatitis B Vaccine Delivered Trans-dermally by MAP
Role: lead
Immunogenicity and Safety Study of Heterologous Booster Vaccination of a SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine(GBP510) Adjuvanted with AS03 in Adults Aged 18 Years and Older
Role: collaborator
Safety and Immunogenicity of Hecolin® in Healthy Pregnant Women
Role: lead
Immunogenicity and Safety Study of SK SARS-CoV-2 Recombinant Nanoparticle Vaccine (GBP510) Adjuvanted With AS03 (COVID-19)
Role: collaborator
Evaluation of Typhoid Conjugate Vaccine Effectiveness in Ghana
Role: lead
A Blood Collection Study to Assess the Immunogenicity of Nationally Authorized Homologous COVID-19 Booster Vaccines Among Adult Vaccinees.
Role: collaborator
A Controlled Phase 2/3 Study of Adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Vaccine (SCB-2019) for the Prevention of COVID-19
Role: collaborator
Immune Non-Inferiority, Safety and Lot-to-Lot Consistency of Oral Cholera Vaccine-Simplified Compared to Shanchol™
Role: lead
Safety and Immunogenicity of COVID-19 Vaccine, AdCLD-CoV19-1
Role: collaborator
Dengue Serostatus Study in the Philippines
Role: collaborator